SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Deep learning-enabled accurate assessment of gait impairments in Parkinson’s disease using smartphone videos

Han, J; Tian, Z; Wu, J; Zhang, K; Li, S; Baig, F; Liu, P; Vaidyanathan, R; Morgante, F; Huo, W (2026) Deep learning-enabled accurate assessment of gait impairments in Parkinson’s disease using smartphone videos. npj Digital Medicine, 9. p. 98. ISSN 2398-6352 https://doi.org/10.1038/s41746-025-02150-8
SGUL Authors: Morgante, Francesca

[img] PDF Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (1MB)
[img] PDF (Supplementary Information) Supporting information
Download (1MB)
[img] PDF (Reporting Summary) Supporting information
Download (1MB)
[img] Microsoft Excel (Supplementary Data) Supporting information
Download (257kB)
[img] Video (MP4) (Supplementary Movie) Supporting information
Download (22MB)
[img] PDF Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (1MB)

Abstract

Gait impairments are among the most prevalent and disabling symptoms in Parkinson's Disease (PD), featuring complex and highly heterogeneous manifestations. Here, we propose a deep learning-based framework to assess gait impairments using smartphone-recorded videos. This framework demonstrated high proficiency in predicting PD severity, with a micro-average area under the receiver operating characteristic curve (AUC) of 0.87 and an F1 score of 0.806, comparable to the average performance of three clinical specialists. Additionally, it effectively discerned the comprehensive efficacy of medications on gait impairments with a precision of 73.68%. In particular, it demonstrated the ability to discriminate medication-induced fine-granular gait changes beyond the resolution of the Unified Parkinson's Disease Rating Scale (UPDRS). Furthermore, our interpretable framework enabled the extraction of traditional clinically used motion markers and the discovery of novel digital biomarkers sensitive to disease progression and medication response. The findings underscore its great potential for efficiently assessing disease progression in both clinical and home settings, as well as evaluating disease-modifying effects in clinical trials to promote personalized therapies.

Item Type: Article
Additional Information: © The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
SGUL Research Institute / Research Centre: Academic Structure > Neuroscience & Cell Biology Research Institute
Academic Structure > Neuroscience & Cell Biology Research Institute > Neuromodulation & Motor Control
Journal or Publication Title: npj Digital Medicine
ISSN: 2398-6352
Language: en
Media of Output: Print-Electronic
Related URLs:
Publisher License: Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0
Projects:
Project IDFunderFunder ID
2022YFB4700200National Key Research and Development Program of Chinahttps://doi.org/10.13039/501100012166
62373202National Natural Science Foundation of Chinahttp://dx.doi.org/10.13039/501100001809
23JCYBJC01200Tianjin Municipal Science and Technology Programhttps://doi.org/10.13039/501100019065
24JCZX JC00340Tianjin Municipal Science and Technology Programhttps://doi.org/10.13039/501100019065
UNSPECIFIEDFundamental Research Funds for the Central Universities of ChinaUNSPECIFIED
PubMed ID: 41390840
Dates:
Date Event
2026-01-29 Published
2025-12-13 Published Online
2025-11-02 Accepted
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/118214
Publisher's version: https://doi.org/10.1038/s41746-025-02150-8

Actions (login required)

Edit Item Edit Item